MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Cardiff Oncology, Inc. Common Stock

CRDF

#3175
Cardiff Oncology, Inc. Common Stock
1.94
-1.02%
Sector:
Base:
Profit Currency:
Daily Range
1.94
1.94
Year Range
1.48
4.56
Daily Change
-1.02%
Monthly Change
-2.51%
6 month change
-12.22%
Year Change
-51.74%
Previous Close
1.96
Open
1.94
Bid
Ask
Low
1.94
High
1.94
Volume
37
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. CRDF
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 202020212022202320242025 TTM

News

Investing Investing
CRDF
2026.02.25
Cardiff Oncology earnings beat by $0.08, revenue topped estimates
Investing Investing
CRDF
2026.01.28
H.C. Wainwright reiterates Buy rating on Cardiff Oncology stock at $10
Seeking Alpha Seeking Alpha
CRDF
2026.01.28
Cardiff Oncology, Inc. (CRDF) Discusses Management Transition and Onvansertib Phase II Data Update in RAS-Mutated mCRC Transcript
Benzinga Benzinga
CRDF
2026.01.28
Why Did Cardiff Oncology Stock Plunge On Tuesday? - Cardiff Oncology (NASDAQ:CRDF)
Investing Investing
CRDF
2026.01.27
Cardiff Oncology stock tumbles after Phase 2 trial data update
Investing Investing
CRDF
2026.01.27
Cardiff Oncology appoints interim CEO amid leadership transition
Investing Investing
CRDF
2026.01.27
Cardiff Oncology reports positive phase 2 data for cancer drug
Seeking Alpha Seeking Alpha
CRDF
2026.01.13
Cardiff Oncology: What Storms Can We Expect In 2026? The Case For Measured Enthusiasm (NASDAQ:CRDF)
Investing Investing
CRDF
2026.01.05
Cardiff Oncology stock initiated with Outperform rating by Noble Capital
Investing Investing
CRDF
2025.12.08
Cardiff oncology reports positive results for onvansertib in leukemia trial
Investing Investing
CRDF
2025.11.11
Cardiff Oncology at Guggenheim Conference: Promising Prospects for Onvansertib
Investing Investing
CRDF
2025.11.06
Cardiff Oncology earnings beat by $0.04, revenue fell short of estimates

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd